May 14, 2024 02:20AM
Aug 16, 2022 04:05PM
Aug 16, 2022 04:05PM
Aug 16, 2022 04:05PM
Aug 16, 2022 04:05PM
Feb 24, 2022 04:05PM
Feb 24, 2022 04:05PM Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results
Dec 6, 2021 07:00AM
Dec 6, 2021 07:00AM
Nov 9, 2021 04:10PM
Nov 9, 2021 04:10PM
Aug 12, 2021 04:05PM
Aug 12, 2021 04:05PM
Jul 27, 2021 08:10AM Kronos Bio Inc. (KRON) Announces FDA Clearance of Investigational New Drug Application for Lanraplenib (LANRA) for Treatment of Patients with Acute Myeloid Leukemia
Jul 27, 2021 08:00AM
Jul 27, 2021 08:00AM
May 11, 2021 04:05PM
May 11, 2021 04:05PM
Mar 23, 2021 04:05PM
Mar 23, 2021 04:05PM
Mar 4, 2021 07:03AM Kronos Bio Inc. (KRON) Announces Positive End-of-Phase 2 Meeting with FDA for Entospletinib in Newly Diagnosed NPM1-mutated Acute Myeloid Leukemia
Mar 4, 2021 07:00AM
Mar 4, 2021 07:00AM
Dec 7, 2020 08:02AM
Dec 7, 2020 08:00AM
Dec 7, 2020 08:00AM

322,882 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All